BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14524032)

  • 21. Community-acquired methicillin-resistant Staphylococcus aureus, a new player in sports medicine.
    Lu D; Holtom P
    Curr Sports Med Rep; 2005 Oct; 4(5):265-70. PubMed ID: 16144584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nosocomial infections: methicillin resistant Staphylococcus auerus in wound infection in Ibadan, Nigeria.
    Okesola AO; Oni AA; Bakare RA
    Afr J Med Med Sci; 1999; 28(1-2):55-7. PubMed ID: 12953988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of a cadexomer iodine wound dressing on methicillin resistant Staphylococcus aureus (MRSA) in acute wounds.
    Mertz PM; Oliveira-Gandia MF; Davis SC
    Dermatol Surg; 1999 Feb; 25(2):89-93. PubMed ID: 10037509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixture of sugar and povidone-iodine stimulates healing of MRSA-infected skin ulcers on db/db mice.
    Shi CM; Nakao H; Yamazaki M; Tsuboi R; Ogawa H
    Arch Dermatol Res; 2007 Nov; 299(9):449-56. PubMed ID: 17680256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of methicillin-resistant Staphylococcus aureus (MRSA) skin infections and MRSA colonization.
    Terushkin V; Brownell I
    J Drugs Dermatol; 2008 Jun; 7(6):597-601. PubMed ID: 18561595
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities.
    Cohen PR
    South Med J; 2005 Jun; 98(6):596-602. PubMed ID: 16004165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What is certain in the topical eradication of MRSA from carriers?].
    Dziekan G; Mlangeni D; Daschner FD
    Dtsch Med Wochenschr; 2001 Jun; 126(25-26):761-3. PubMed ID: 11455670
    [No Abstract]   [Full Text] [Related]  

  • 29. [Methicillin-resistant Staphylococcus aureus (MRSA), a predictor of the end of the antibiotic era--diagnosis, epidemiology, therapy and dissemination prevention].
    Tambić A
    Lijec Vjesn; 1997; 119(5-6):166-71. PubMed ID: 9379825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methicillin-resistant Staphylococcus aureus versus the burn patient.
    Cook N
    Burns; 1998 Mar; 24(2):91-8. PubMed ID: 9625231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection.
    Moellering RC
    Clin Infect Dis; 2008 Apr; 46(7):1032-7. PubMed ID: 18444820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections.
    Frazee BW; Lynn J; Charlebois ED; Lambert L; Lowery D; Perdreau-Remington F
    Ann Emerg Med; 2005 Mar; 45(3):311-20. PubMed ID: 15726056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The epidemiology of methicillin-resistant Staphylococcus aureus colonisation and infection.
    Doebbeling BN
    J Chemother; 1995 Jul; 7 Suppl 3():99-103. PubMed ID: 8609545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers.
    Tentolouris N; Petrikkos G; Vallianou N; Zachos C; Daikos GL; Tsapogas P; Markou G; Katsilambros N
    Clin Microbiol Infect; 2006 Feb; 12(2):186-9. PubMed ID: 16441460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].
    Bernard P; Jarlier V; Santerre-Henriksen A
    Ann Dermatol Venereol; 2008 Jan; 135(1):13-9. PubMed ID: 18342068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Community-acquired methicillin resistant Staphylococcus aureus skin and soft tissue infections in Madrid: prevalence study].
    Casado-Verrier B; Gómez-Fernández C; Paño-Pardo JR; Gómez-Gil R; Mingorance-Cruz J; Moreno-Alonso de Celada R; Herranz-Pinto P
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):300-6. PubMed ID: 22260847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methicillin-resistant Staphylococcus aureus (MRSA) and wounds.
    Shovein J
    Ostomy Wound Manage; 1993; 39(6):20-4. PubMed ID: 8216681
    [No Abstract]   [Full Text] [Related]  

  • 38. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
    Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections presenting to the Emergency Department of a Canadian Academic Health Care Center.
    Achiam CC; Fernandes CM; McLeod SL; Salvadori MI; John M; Seabrook JA; Theakston KD; Milburn S; Hussain Z
    Eur J Emerg Med; 2011 Feb; 18(1):2-8. PubMed ID: 20168235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Methicillin-resistant Staphylococcus aureus (MRSA) in the community].
    Vonk AG; Vandenbroucke-Grauls CM
    Ned Tijdschr Geneeskd; 2007 Feb; 151(7):401-7. PubMed ID: 17343138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.